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Carpenter syndrome is a pleiotropic disorder with autosomal recessive inheritance, the cardinal features of which include
craniosynostosis, polysyndactyly, obesity, and cardiac defects. Using homozygosity mapping, we found linkage to chro-
mosome 6p12.1-q12 and, in 15 independent families, identiﬁed ﬁve different mutations (four truncating and one mis-
sense) in RAB23, which encodes a member of the RAB guanosine triphosphatase (GTPase) family of vesicle transport
proteins and acts as a negative regulator of hedgehog (HH) signaling. In 10 patients, the disease was caused by homo-
zygosity for the same nonsense mutation, L145X, that resides on a common haplotype, indicative of a founder effect
in patients of northern European descent. Surprisingly, nonsense mutations of Rab23 in open brain mice cause recessive
embryonic lethality with neural-tube defects, suggesting a species difference in the requirement for RAB23 during early
development. The discovery of RAB23 mutations in patients with Carpenter syndrome implicates HH signaling in cranial-
suture biogenesis—an unexpected ﬁnding, given that craniosynostosis is not usually associated with mutations of other
HH-pathway components—and provides a new molecular target for studies of obesity.
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Carpenter syndrome (MIM %201000), also known as “ac-
rocephalopolysyndactyly type II,” is a rare autosomal re-
cessive disorder characterized by craniosynostosis, obesity,
polydactyly, and soft-tissue syndactyly (ﬁg. 1).1–3 Unlike
other inherited craniosynostoses, which most commonly
affect the coronal sutures, fusion of the midline (metopic
and sagittal) sutures is typical in Carpenter syndrome; se-
vere cases have cloverleaf skull. Other well-recognized fea-
tures include brachydactyly with shortening or absence
of the middle phalanges, molar agenesis, genu valgum,
hypogenitalism, congenital cardiac defects, umbilical her-
nia, and learning disability.3–5 Although the molecular ba-
sis of many craniosynostosis syndromes is now well de-
scribed, with mutations of ﬁbroblast growth-factor recep-
tors, ephrins, or the transcription factor TWIST most fre-
quently identiﬁed,6 the etiology of Carpenter syndrome
has been elusive.
We mapped the disease locus, using a large family (fam-
ily 1; subjects 3541, 3589, and 3593) from the United
States.7 After approval from the Oxfordshire Research
Ethics Committee and the local institutional reviewboard,
DNA was collected with informed consent from six sib-
lings (three affected and three unaffected) and both par-
ents. The parents were not known to be related, but, of
their eight grandparents, three of the father’s and two of
the mother’s had been born in the same city, raising the
possibility of a distant consanguineous loop. We also an-
alyzed an affected male (family 2; subject 3624) whose
Danish parents were ﬁrst cousins; in addition to the classic
features of Carpenter syndrome, subject 3624 had a lum-
barmyelomeningocele. Using theGeneChipHumanMap-
ping 50K Array Hind240 (Affymetrix), we undertook ge-
nomewide SNP genotyping and performed parametricmul-
tipoint linkage analysis, allowing for heterogeneity, using
GENEHUNTER-MODSCORE software.8 In the absence of
consanguinity in family 1, no signiﬁcant linkage was ob-
stained (themaximumpossible heterogeneity LOD [HLOD]
score of 2.7 was found for three different regions of the
genome); however, when a consanguineous loop (conser-
vatively assigned as second-cousin parents) was intro-
duced, the HLOD score increased dramatically for just one
of these regions, to a maximum of 4.8, for families 1 and
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Figure 1. Clinical features of Carpenter syndrome. A, Affected
sister of subject 4009, aged 6 years. Note metopic ridge and tem-
poral bulging secondary to multisuture synostosis, arched eye-
brows, epicanthic folds, anteverted nares, and broad thumbs and
halluces with syndactyly, brachydactyly, clinodactyly, and polydac-
tyly (postaxial in hands, central in feet). B, Severe bilateral club-
foot in subject 4009. C, Three-dimensional CT skull reconstruction
of subject 3541, aged 4 wk, showing complete synostosis of the
metopic, sagittal, and coronal sutures. D, Preoperative radiographs
of the hands and feet of subject 3734, aged 11 years. Note char-
acteristic longitudinally split epiphyses at bases of several prox-
imal phalanges, central polydactyly of the feet, and biphalangeal
digits II of the hands and II and III of the feet.
2 combined, at chromosome 6p12.1-q12 (ﬁg. 2A). The
ﬂanking heterozygous SNPs in family 1 were rs7766181
and rs10498828, and the affected individual in family 2
was homozygous throughout this region.
The interval of homozygosity shared by the two fami-
lies contained 24 annotated genes (Ensembl Genome
Browser). Initially, we considered BMP5 a candidate, be-
cause mutation of murine Bmp5 causes a range of skeletal
defects resulting in the short ear phenotype9; however, no
mutations were found. We next analyzed RAB23; recessive
nonsense mutations in the orthologousmurine Rab23 gene
cause neural-tube defects, abnormal somites, polydactyly,
and poorly developed eyes (opb [open brain] locus).10–12
With use of the primers listed in table 1, direct sequencing
of the seven exons and surrounding intronic regions of
RAB23 revealed an identical homozygous 434TrA trans-
version encoding an L145X nonsense mutation (ﬁg. 3A)
in the four affected individuals from families 1 and 2, as
well as in a further sporadic case (subject 3734). These ﬁve
subjects were all identically homozygous for 30 fully ge-
notyped consecutive SNPs on the Affymetrix 50K array
(from rs10484709 to rs1577630) (ﬁg. 2B), indicating that
they were very likely to share a single ancestral mutation
(see below).
To expand the mutation spectrum in RAB23, we ascer-
tained 12 additional unpublished Carpenter syndrome
cases unrelated by family history. Including the three fam-
ilies described above, the 15 independent families in-
cluded 17 affected individuals from whom DNA was avail-
able; 6 cases arose from known consanguineous unions.
The families originated from the United Kingdom (ﬁve),
Brazil (ﬁve), The Netherlands (three), and Denmark and
the United States (one each). The clinical features of these
17 cases, which represent the largest series of subjects
with Carpenter syndrome to date, are presented in table
2. Craniosynostosis was present in all individuals, with
the sutures affected with relative frequency sagittal1me-
topic1coronal1lambdoid. Abnormalities of the hands in-
cluded postaxial polydactyly (9 of 17 cases), broad or biﬁd
thumbs (6 of 17), cutaneous syndactyly (12 of 17), and
absent middle phalanges (9 of 11). In the feet, preaxial or
central polydactyly (16 of 17) and syndactyly (17 of 17)
were nearly always present. High birth weight (9 of 9) and
obesity (9 of 10) were prevalent. Other signiﬁcant com-
plications included umbilical hernia (8 of 17), congenital
heart disease (3 of 17), deformities of the knees (4 of 14)
or ankles (4 of 17), and cryptorchidism or hypoplastic
testes in males (6 of 8). Brain imaging showed abnormal-
ities in 7 of 10 subjects; 3 of 16 had hydrocephalus re-
quiring insertion of a shunt. Signiﬁcant learning disability
was present in 6 of 13 individuals. The occurrence of an
open neural-tube defect (family 2; subject 3624), although
not previously described in Carpenter syndrome, is un-
likely to be coincidental, because this is a cardinal feature
of Rab23 mutation in the mouse; the mother of subject
3624 had taken periconceptional folic acid supplements.
Pathogenic sequence variants were found in all individ-
uals with the classic phenotype (table 3 and ﬁg. 3A), show-
ing that mutations of RAB23 are the major cause of Car-
penter syndrome. We identiﬁed ﬁve different mutations,
all of which predict a loss of function. Four (E48fsX7,
Y78fsX30, E137X, and L145X) of the ﬁve alleles are non-
sense or frameshifting mutations that would generate trun-
cated proteins. We identiﬁed a single missense mutation,
C85R, encoding a nonconservative substitution from an
uncharged to a charged amino acid; this residue is in-
volved in b-sheet formation and is completely buried in
the core of the protein (ﬁg. 4),13,14 suggesting that this
substitution would disrupt normal folding of RAB23. This
mutation was present in individual 3961, who was a com-
pound heterozygote for the C85R and L145X alleles; all
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Figure 2. Linkage and haplotype mapping of Carpenter syndrome to chromosome 6p12.1. A, Genomewide HLOD scores from 50K
microarray data for families 1 and 2 combined, with the assumption of a consanguineous loop (second-cousin parents) in family 1.
HLOD scores are given along the Y-axis, relative to genomic position (cM) on the X-axis. Note the signiﬁcant peak (HLOD 4.8) in the
centromeric region of chromosome 6. B, Representation of 50K SNP haplotypes (vertical bars) for chromosomes of affected individuals
in families 1 and 2 and an additional sporadic case (subject 3734), all of whom are homozygous for the 434TrA (L145X) mutation in
RAB23. Distinct haplotypes are represented by different shaded bars. On the basis of homozygosity, the critical region on chromosome
6 is deﬁned by heterozygosity for SNPs rs7766181 (family 1) and rs1689237 (subject 3734). Within this, a smaller region (white bars)
is identical in all affected individuals for 30 consecutive SNPs, suggesting a common ancestral origin of the L145X mutation. C,
Genotyping of 13 selected SNPs spanning this identical segment in 10 individuals homozygous for the L145X mutation and 2 individuals
homozygous for E137X. At left, the position of these SNPs is shown in relation to RAB23 and 8 additional genes within the 6p12.1-
q11 region. Note that all patients with the L145X mutation share a common haplotype for seven consecutive SNPs; this is interrupted
proximally in two Dutch patients, probably because of a shared recombination. From top to bottom, the genotyped SNPs are rs1925179,
rs2397214, rs9296842, rs1547625, rs6927258, rs6906792, rs3904827, rs6934928, rs1343391, rs1224703, rs1850417, rs2343013, and
rs1689237. BrapBrazil; DenpDenmark; NethpThe Netherlands.
other affected individuals appeared homozygous for their
particular mutation.When samples were unavailable from
both parents but we had sufﬁcient proband DNA, we ex-
cluded the possibility that one allele harbored a deletion
(table 3) by multiplex ligation-dependent probe-ampliﬁ-
cation (MLPA) analysis using synthetic oligonucleotide
probes to RAB23 exons 1, 3, and 7 (MRC-Holland). All
mutations were absent in 292 control chromosomes, as
assessed by diagnostic restriction digests (ﬁg. 3A and table
4).
The L145X mutation was apparently homozygous in 10
probands (3 each from the Netherlands and the United
Kingdom, 2 from Brazil, and 1 each from the United States
and Denmark), 3 of whom had been shown by the Affy-
metrix SNP analysis to share a common haplotype around
the mutation (ﬁg. 2B). To check whether any of the other
cases had arisen from an independent mutation, we geno-
typed them for a subset of 13 SNPs around RAB23 (table
5). All 10 patients shared a commonhaplotype comprising
7 SNPs and spanning 2.2 Mb. This haplotype—which, ac-
cording to HapMart (International HapMap Project), is
present in only 11 of 120 Utah-CEPH chromosomes from
HapMap16—was delimited by ancestral recombinations,
distally in the Danish family and proximally in twoDutch
families, and contains only eight genes in addition to
RAB23 (ﬁg. 2C). These data indicate that a founder effect,
Table 1. Primers Used for PCR Ampliﬁcation of RAB23
Primer
Primer Sequence
(5′r3′)
Product
Size
(bp)
Wave
Temperature(s)
(C)Forward Reverse
RAB23_1 CTCCACCCTGGCATTTAGAC AACAGCCCTTTTCAGACCCT 270 59
RAB23_2 CCACAGATTTGAGAGGGAAGA AGTTGCCACACCTCGAAATC 333 56.4
RAB23_3 TTACCAAAAACATTTTCCTTTACA GCCAAAATAATATGCCCAAA 188 54
RAB23_4 TGTTAATGTAAATACCTTGATTGATTG TATAGAATTACTGTCCCTCCTTCCC 250 56.5 and 58.5
RAB23_5 AAACAAGCTATCAGAAGGCACC CAACACAATTTTAAAAGCGCA 207 54.5
RAB23_6 ATCATTGACCTGGTTCTGGG TCACTTTTAAATCACATTTCTGAAAGA 228 55
RAB23_7 TAACTCAGGCGTGTCAGTGG ATGACAGCTGGATGGGTTTC 256 57
NOTE.—DNA was obtained from whole-blood samples by phenol-chloroform extraction and was ampliﬁed in
a total volume of 25 ml containing 15 mM TrisHCl (pH 8.0), 50 mM KCl, 2.5 mM MgCl2, 100 mM each deoxy-
nucleoside triphosphate, 0.5 mM primers, and 0.75 units of Amplitaq Gold polymerase (Applied Biosystems).
All PCRs were performed using an annealing temperature of 60C. Cycling conditions consisted of an 8-min
denaturation step at 94C, followed by 35 cycles at 94C for 30 s, at 60C for 30 s, and at 72C for 60 s,
with a ﬁnal extension at 72C for 10 min.
Figure 3. RAB23 mutations in Carpenter syndrome. A, Sequence chromatograms and conﬁrmatory restriction digests for the ﬁve
pathogenic mutations identiﬁed. Note that patient 3961 is a compound heterozygote for the C85R and L145X mutations. B, top, The
exon/intron organization of RAB23, with the coding part of the cDNA (GenBank [accession number NM_183227.1]; Ensembl Genome
Browser [reference OTTHUMG00000014918]) in black and the UTRs in white (alternatively spliced 5′ noncoding exons omitted). Plain
numbering refers to the ﬁrst nucleotide of each exon, starting from the initiation codon, and italic numbering indicates the length of
introns. Bottom, Functional domains in the 237-aa protein,13,14,17 color coded, with the location of human mutations causing Carpenter
syndrome and those found in open brain mice12 indicated by red and green dots, respectively. GDPpguanosine diphosphate.
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Table 2. Clinical Features of Patients with
Mutations in RAB23
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 3. RAB23 Mutations in Patients with Carpenter Syndrome
Subject Sex Parental Consanguinity
Country of
Origin Ethnicity
Sample(s)
Analyzeda
Mutation at Allele
Maternal Paternal
DNA Protein DNA Protein
3965 M  United Kingdom White C and M 140_141insA E48fsX7 140_141insA E48fsX7
3983 F 1st cousin Brazil African/white C and M 232delT Y78fsX30 Sameb 
3961 F  United Kingdom White C, M, and F 434TrA L145X 253TrC C85R
3978 F  Brazil African/white C and M 408_409insT E137X 408_409insT E137X
3980 F 1st cousin once removed Brazil White C, M, and F 408_409insT E137X Same 
3541 (Family 1) M  United States White C, M, and F 434TrA L145X 434TrA L145X
3589 (Family 1) F  United States White C, M, and F 434TrA L145X 434TrA L145X
3593 (Family 1) M  United States White C, M, and F 434TrA L145X 434TrA L145X
3624 (Family 2) M 1st cousin Denmark White C, M, and F 434TrA L145X Same 
3734 F  United Kingdom White C and M 434TrA L145X 434TrAb L145X
3947 M  Netherlands White C, M, and F 434TrA L145X 434TrA L145X
3971 M 1st cousin Netherlands White C, M, and F 434TrA L145X Same 
3975 M 1st cousin Brazil White C, M, and F 434TrA L145X Same 
3985 F  United Kingdom White C, M, and F 434TrA L145X 434TrA L145X
4008 F  Netherlands White C 434TrA L145X 434TrA L145X
4009 M 1st cousin Brazil African C, M, and F 434TrA L145X Same 
4059 M  United Kingdom White C 434TrA L145X 434TrA L145X
NOTE.—Nucleotide numbering of RAB23 cDNA is based on GenBank sequence NM_183227.1 but starts from the ﬁrst base of the initiation codon. For cases in which
the two parental alleles are very unlikely to be independent (due to known consanguinity), the paternal allele is denoted “Same.”
a Cpchild; Mpmother; Fpfather.
b Complete deletion of one allele was not formally excluded by MLPA analysis.
rather than a recurrentmutation, underlies Carpenter syn-
drome in patients of northern European descent and does
not support the possibility that the L145X mutation has
particular functional consequences (see below). Two pa-
tients from eastern Brazil both appeared homozygous
for the E137X mutation, which resides on a shared hap-
lotype spanning at least 5.8 Mb (ﬁg. 2C). The E48fsX7 and
Y78fsX30 mutations were each found in one patient only.
To explore whether RAB23 mutations play a more gen-
eral pathological role either in craniosynostosis or in limb
malformations, we screened respective patient panels by
a combination of Wave denaturing high-performance liq-
uid chromatography (Transgenomic) and diagnostic re-
striction digests for mutations identiﬁed in Carpenter syn-
drome.DNA from256patientswith craniosynostosis (nega-
tive for the common mutations in the FGFR1, FGFR2,
FGFR3, and TWIST1 genes),6 202 patients with limb mal-
formations requiring plastic surgery, and 163 control in-
dividuals was analyzed using the assays detailed in tables
1, 4, and 6. None of the Carpenter syndrome mutations
(table 3) were identiﬁed in any of these cohorts. Although
six novel alleles—including an amino acid substitution,
an amino acid deletion, and a nonsense mutation (all in
the heterozygous state)—were found in the patient groups
(table 6), none appeared related to the clinical phenotype.
An additional common nonsynonymous SNP c.619GrA
(p.G207S; rs1040461) was present, for which all three ge-
notypes were identiﬁed in unaffected individuals in the
HapMap panel.16 These results show thatRAB23mutations
do not frequently contribute either to craniosynostosis or
to limb malformations.
Rab23, ﬁrst isolated from the mouse in 1994,17 belongs
to the RAB family of 160 small guanosine triphosphatases
(GTPases) that regulate intracellular trafﬁcking of mem-
brane-associated proteins13–15; other family members for
which germline mutations cause human disorders are
RAB7 (Charcot-Marie-Tooth disease type 2B, dominant in-
heritance [MIM #600882])18 and RAB27A (Griscelli syn-
drome type 2, recessive inheritance [MIM#607624]).19Our
ﬁnding of RAB23 mutations in Carpenter syndrome is un-
expected, because similar nonsense mutations of the or-
thologous murine Rab23 gene (encoding K39X and R80X)
in opb mice cause recessive embryonic lethality with exen-
cephaly.10–12 It is unlikely that the human RAB23 muta-
tions represent partial loss-of-function alleles of lesser se-
verity than do the murine ones, for two reasons. First,
prenylation at a consensus site in the C-terminus of RAB
proteins by RAB geranylgeranyl transferase is essential for
their correct membrane targeting,15 predicting that all
truncating mutations should result in complete loss of
function. Second, two of the human truncatingmutations
(E48fsX7 and Y78fsX30) occur upstream of the opb mu-
tation R80X (ﬁg. 3B),12 yet neural-tube defects were absent
in the affected individuals. Consistent with this, we did
not ﬁnd any clear genotype-phenotype correlation for the
human mutations, although the fetus 3965, with themost
N-terminal truncation (E48fsX7), was the only subject ter-
minated antenatally and might represent a more severe
phenotype (table 2).
The original identiﬁcation of Rab23 mutations in opb
mice was driven by genetic studies to identify modiﬁers
of hedgehog (HH) signaling in the neural tube. In mam-
mals, there are three paralogous HH genes—Shh, Ihh, and
Figure 4. Sequence conservation and structural context of C85R substitution. A, Amino acid sequence comparison of the Switch 2
region of human RAB23 (top) with 13 other species. The consensus sequence is shown at the bottom, and the position of the mutated
C85 residue is indicated with an arrow. B, Structure of human RAB2314 (Protein Data Bank [number 1Z22]), showing the C85 residue
located in a b-strand (blue) and completely buried in the core of the protein. The bound Mg-GDP is shown in yellow. The structure was
modeled using the Protein Workshop tool (Protein Data Bank).
Table 4. Primers and Restriction Enzymes Used for Conﬁrmation of RAB23
Mutations
Mutation and Primer Primer Sequence (5′r3′)a
Product
Size
(bp)
Restriction
Enzyme
E48fsX7: 157 XcmI ()
E48fsXdigF AAAGACTACAAGAAAACCATTGCCATTG
RAB23_2R AGTTGCCACACCTCGAAATC
Y78fsX30: 188 StuI ()
RAB23_3F TTACCAAAAACATTTTCCTTTACA
RAB23_3R GCCAAAATAATATGCCCAAA
C85R: 156 BssSI ()
C85RdigF TTTGAATGGATAAAAGTTGCCC
C85RdigR TTCCCTATCTGTGGTAGAGAACTCGAGC
E137X: 207 HindIII ()
RAB23_5F AAACAAGCTATCAGAAGGCACC
RAB23_5R CAACACAATTTTAAAAGCGCA
L145X: 120 HpaI ()
RAB23_5F AAACAAGCTATCAGAAGGCACC
RAB23_L145XdigR TTCTTTCACTGATGTTCTGTAGAATGTT
NOTE.—PCRs were performed using the same conditions as described in table 1.
a Nucleotides shown in bold represent mismatches incorporated into primers to engineer di-
agnostic restriction sites.
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Table 5. Primers and Restriction Enzymes Used for
Haplotype Analysis
Primer
Primer Sequence
(5′r3′)
Product
Size
(bp) Assaya
rs1925179F GGCAGCTTTCTTCCTGACTG 188 Hpy188I
rs1925179R TTACATTTCAAAGGGGTGGC
rs2397214F GGCCTGTGATTTGAGTGGTT 165 MnlI
rs2397214R TCTCTTGTGACCAGATGCCA
rs9296842F CTGAAGTTGCATTCTTGCCA 165 BtsCI
rs9296842R AAATTAAAAATCAGTGTCCTGCAA
rs1547625Fseq CCTGGCCTCATCCTACCATA 154 Seq
rs1547625Rseq TGCCTGAGAAAAATGAGGCT
rs6927258F TTCTGATCATGATGTAGTGCCA 218 MboI
rs6927258R GGGCTTGGCATCTCTGAGTA
rs6906792Fseq CAGAAACTTGGCAACAAAATG 182 Seq
rs6906792Rseq TTCCTGGAATTTAAAAGGTAGCA
rs3904827F ACTGCATACCGCTTACCAAA 275 Tsp509I
rs3904827R TCCAGACAAACAAAGGCTGA
rs6934928F AAGTGGCTTATTTCCTCCAAGA 180 RsaI
rs6934928R GCCCAAATCCATGTAACTTCT
rs1343391Fseq AAGGAGAGGGAGAGACCGAG 187 Seq
rs1343391Rseq AGCACATGATATGCCCACTT
rs1224703F AATAGGGCAGAAGGGTGCTC 195 Tsp509I
rs1224703R ACCCACCAAAGAGACGTGAG
rs1850417F CTTTAACTCCATTTTAAGGGACAG 190 EarI
rs1850417R AACAAAGCTTGGAGAAGCAAA
rs2343013F TGTGTTCCCAAACTGCTGAA 221 MwoI
rs2343013R CATCTCCCCCGGTTAAACTT
rs1689237Fseq TGAGGGATCTGGGATGCTAC 157 Seq
rs1689237Rseq TTTAGCTCTCACTGCATGGC
NOTE.—PCRs were performed using the same conditions as described
in table 1.
a Seqpanalysis by DNA sequencing.
Table 6. RAB23 Variants Identiﬁed in Patients with Craniosynostosis and Limb Malformations
dbSNP
Accession
Number Nucleotide
Amino
Acid
Exon
(Intron)
No. of Heterozygotes
Present in
Unaffected
Parenta
Restriction
Digest
With
Craniosynostosis
( )Np 256
With Limb
Malformation
( )Np 202
Controls
( )Np 163
ss69357975 c.1–49CrG  (1) 2 0 0 NT Hpy188III ()
ss69357972 c.39_41del p.V13del 2 1 0 0 NA XcmI ()
ss69357968 c.119ArG p.K40R 2 0 0 1  NT
ss69357974 c.15544CrA  (2) 0 0 1  NT
ss69357973 c.242–15_-12del  (3) 0 1 0 NA NT
ss69357971 c.247CrT p.Q83X 4 1 0 0 NA BfaI ()
ss69357970 c.301TrG p.S101A 4 5 2 2 2 (5 NA) MwoI ()
ss69357969 c.57428GrA  (6) 0 1 1 NA NT
NOTE.—NTpnot tested.
a NApone or both parents unavailable for testing.
Dhh—encoding the sonic, Indian, and desert HH proteins,
respectively.20,21 The opb locus was initially described in a
sporadically occurring mouse mutant with exencephaly10
(a variably expressed phenotype observed on both C57Bl/
6 and C3H backgrounds).10,11 Subsequently, a second allele
was isolated in an ethylnitrosoureamutagenesis screen for
recessive embryonic lethal mutations22; nonsense muta-
tions of Rab23 were demonstrated in both strains.12 Ho-
mozygosity for these opb mutations rescues many of the
morphological defects in Shh/ mice, with Shh/opb dou-
ble-mutant mice largely resembling opb single mutants,
indicating that the Rab23 mutations bypass the require-
ment for Shh.12 In the neural tube, mutation of Shh has
opposite consequences to mutation of Rab23, causing loss
(Shh) and expansion (Rab23) of ventral markers; Patched1,
a transcriptional target of Shh signaling, is activated in
opb mice, showing that Rab23 is a negative regulator of
HH signaling.11,12 Genetic analysis of epistatic relationships
shows that Rab23 acts downstream of the key HH signal-
ing intermediate Smoothened but upstream of both the
effector transcription factors Gli2 and Gli323 and the in-
traﬂagellar transport proteins (such as those encoded by
Ift88/polaris and Ift172/wim), required for their capacita-
tion.24 As such, Rab23 is one of a number of genes (in-
cluding iguana, talpid3, Fkbp8, and Ift family members)
implicated in the regulation of Gli transcription–factor
processing speciﬁcally in vertebrates21,25 and is the ﬁrst of
these implicated in a human disorder. Rab23 localizes to
membranes26,27 and is expressed at multiple sites in the
mouse, including embryonic neural tube, limb bud, bran-
chial arches, tooth and palate,12,28,29 and adult brain27; how-
ever, its precise membrane-transport activity has not been
deﬁned.
Given the evidence that Rab23 regulates the HH path-
way, it is not surprising that some aspects of the pheno-
type of Carpenter syndrome resemble other human dis-
orders associated with disturbed HH signaling. Most no-
tably, the combination of postaxial polysyndactyly of the
hands and preaxial polysyndactyly of the feet is very sim-
ilar to the pattern that occurs in Greig syndrome (MIM
#175700), which is due to haploinsufﬁciency of GLI3,30
and is consistent with the observed reduction in the pro-
portion of Gli3 repressor in Rab23-mutant embryos.23 The
brachydactyly present in Carpenter syndrome, character-
ized by hypoplasia or absence of the middle phalanges,
resembles brachydactyly type A1, which is caused by het-
erozygous missense mutations in IHH that appear to clus-
ter on one surface of the protein and disrupt phalangeal
patterning by an unknown mechanism.31 However, the
viability of the human RAB23 homozygous mutations in
Carpenter syndrome uncovers several phenotypes (table
2), not previously observed in the lethal opb mouse mu-
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tants,10–12,22 that are not well recognized features of per-
turbed HH signaling.20 Particularly interesting are the cra-
niosynostosis and tendency to postnatal obesity, which
may provide new clues for dissecting the pathophysiology
of these phenotypes.
Relatively little is known about the role of HH signaling
in the cranial sutures. In mice, Shh is expressed in the
osteogenic fronts of the parietal bones and sagittal sutures
only at a relatively late stage of suture development (em-
bryonic day 17),32 and Shh/ mice die too early to assess
the developmental contribution to the cranial sutures. Al-
though endochondral ossiﬁcation is characteristically de-
ﬁcient in Ihh/mice,membranous ossiﬁcation of the skull
vault is maintained33; however, there are no published
data on the expression pattern of Ihh in the sutures. Our
work should stimulate efforts to identify the active HH
ligand(s) and to explore the extent to which the well-
documented developmental relationship among HH sig-
naling, twist, and FGF receptors in the limbs34 is recapitu-
lated in the cranial suture. There is a potential pathophys-
iological link with Antley Bixler syndrome (MIM #207410),
another recessively inherited craniosynostosis caused by
mutations in P450 oxidoreductase (POR).35 POR is the single
ﬂavoprotein involved in electron transfer to all cytochrome
P450 enzymes, including several involved in cholesterol
biosynthesis, defects of which disrupt HH signaling.36
Although postnatal obesity (which has a central distri-
bution) is practically universal in subjects with Carpenter
syndrome, its neuroendocrinological and biochemical ba-
ses are not known. Obesity has not been described else-
where in mammalian disorders of HH signaling20 and was
not observed in opb mice, probably because of embryonic
lethality. Pharmacological approaches have previously sug-
gested that HH signaling may regulate adipogenesis, but
the results have been conﬂicting as to whether this effect
was inhibitory or stimulatory.37 The association of RAB23
mutations with obesity may provide new insight into the
role of HH signaling in the control of fat metabolism.
Alternatively, this phenotype may reﬂect either the reg-
ulation of RAB23 itself (possibly by bone morphogenetic
proteins)12 or downstream HH-independent processes.
The possible interaction of RAB23 with cilia21 suggests an
overlap with the Bardet-Biedl syndromes, which are cil-
iopathies that also feature obesity and polydactyly.38
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